
Suzhou
688266.SSSuzhou Zelgen Biopharmaceuticals Co., Ltd. Price (688266.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
255,580,499
(6.4919)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $45.3-96.18
- Market Cap 25.10B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Zelin Sheng
- IPO Date: January, 23, 2020
- Country: CN
- Currency: CNY
- Headquaters: No Data
- Employees: 867
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
